What is MRNA's current stock price?

As of now, MRNA is trading at $24.13, with a daily change of +2.33%.

What is MRNA next earnings date?

MRNA next earnings report is scheduled for Nov 6, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

MRNA Stock Analysis & IQ Rating | Moderna

MRNA

Moderna

$24.13

+$0.57 | +2.33%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 56.7

MKT CAP

$ 9.42B

52W Low

$ 23.15

VOL

$ 14.40M

P/E Ratio

N/A

AVG VOL

$ 10.95M

RSI

42.41

TREND

Sideways

MRNA Stock IQ

Login to see Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MRNA Target Price

Login to display

Strengths

MRNA Rewards

Earnings are forecast to grow

MRNA Rewards

Investors confidence is positive

MRNA Rewards

Upgraded on attractively valued

MRNA Rewards

Outperform the market

Chart

$27.53 (-12.35%)

$26.89 (-10.26%)

$26 (-7.19%)

$37.29 (-35.29%)

1year

6month

3month

1month

MRNA Risk Level

MRNA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low

LOW

HIGH

MRNA Analysts Opinion

MRNA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

MRNA Analysts Opinion

MRNA Analysts opinion is positive but there was a setback from the past 3 months

MRNA Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

25%

82%

MRNA Street Opinion

MRNA Street view is bullish and have positive views on the near-term outlook

MRNA Performance Sentiment

Sentiments overview associated with MRNA events and the stock performance.

55%

39%

Positive

Negative

21 out of 38
events present

15 out of 38
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$27.16

Resistance
Price

$24.70

Current Price Range

$28.49

Show methods +

MRNA Earnings

The TTM reflects 12-month period, providing review of MRNA financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

3,055

3,199

6,754

-32.74%

Cost of Revenue

1,462

1,464

4,693

-44.19%

Gross Profit

1,593

1,735

2,061

-12.08%

Operating Exp

4,866

5,680

6,300

-12.11%

Operating Inc

-3,273

-3,945

-4,239

-

Net Interest Inc

351

401

383

-4.27%

Interest Exp

14

24

38

-39.30%

Interest Inc

365

425

421

-6.89%

Other Inc Exp

-23

-63

-86

-

EPS Growth

-7.51

-9.28

-12.33

-

MRNA Financial Health

The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals

Financial Score

2.34

Next Earnings Date: Nov 6, 2025

Linked to MRNA

IQ

Close Price

Change

NVAX

3.74

7.76

+0.39%

AMGN

3.88

315.11

-1.73%

VALN

2.05

8.86

-1.56%

MRNA Latest Analysis +

Moderna posts Q3 beat even as weak vaccine sales drive revenue slump.

Today

$24.13 | +2.33%

Activity

Momentum

Moderna Surges. Covid Vaccine Sales Decline But Top Expectations.

Today

$24.13 | +2.33%

Activity

Earnings

Moderna GAAP EPS of -$0.51 beats by $1.67 revenue of $1.02B beats by $150.11M.

Today

$24.13 | +2.33%

Earnings

Earnings Snapshot: Moderna tops Q3 guides FY revenue below consensus after 47% COVID-19 vaccine sales drop.

Today

$24.13 | +2.33%

Earnings

Moderna (MRNA) Stock Is Trading Lower Friday: Whats Going On?. MRNA) shares are trading lower on Friday afternoon giving back a portion of the gains seen on Thursday. Here’.s what investors need to know.The optimism from the rumor appears to have been tempered by the company’.s recent clinical and financial outlook. On Oct. 23 Moderna it was stopping its Phase 3 trial for its cytomegalovirus vaccine mRNA-1647 after it failed to ...

Fri Oct 31, 2025

$27.16 | -3.48%

Momentum

Moderna: Focus On Cancer Vaccines Not Buyout.

Fri Oct 31, 2025

$27.16 | -3.48%

Activity

Moderna gains on report it held talks with at least one large drugmaker.

Thu Oct 30, 2025

$28.14 | +13.93%

Momentum

Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline. Moderna (MRNA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Oct 30, 2025

$28.14 | +13.93%

Earnings

Notable Friday Option Activity: MRNA MDB RKLB. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Moderna Inc (Symbol: MRNA) where a total of 91472 contracts have traded so far representing approximately 9.1 million underlying shares. That amounts to about 99.2% o

Fri Oct 24, 2025

$26.74 | +1.87%

Momentum

UBS Maintains Moderna (MRNA) Buy Recommendation. Fintel reports that on October 23 2025 UBS maintained coverage of Moderna (NasdaqGS:MRNA) with a Buy recommendation. Analyst Price Forecast Suggests 80.47% Upside

Fri Oct 24, 2025

$26.74 | +1.87%

Rating

FAQ About MRNA Stock Insights

What is MRNA current stock price?

What are MRNA stock strengths?

What risks are associated with MRNA stock?

When is MRNA next earnings report?

What is MRNA market cap and volume?

What is MRNA's current Stock IQ?

Should I buy MRNA stock right now?

Is MRNA a Strong Buy right now?

What does a 'Strong Buy' rating mean for MRNA?

What does a 'Strong Sell' rating mean for MRNA?

What factors influence MRNA's Stock IQ?

Explore our MRNA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MRNA Stock Strategies
Effective Risk Management

FIND US ON

Receive our MRNA Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

MRNA

Moderna

Current Price

$24.13

+$0.57 | +2.33%

52W High

$ 56.7

MKT CAP

$ 9.42B

52W Low

$ 23.15

VOL

$ 14.40M

P/E Ratio

N/A

AVG VOL

$ 10.95M

RSI

42.41

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

MRNA Rewards

Earnings are forecast to grow

MRNA Rewards

Investors confidence is positive

MRNA Rewards

Upgraded on attractively valued

MRNA Rewards

Outperform the market

Linked to MRNA

Symbol

IQ

Close

Change

NVAX

3.74

7.76

+0.39%

AMGN

3.88

315.11

-1.73%

VALN

2.05

8.86

-1.56%

MRNA Stock IQ

Login to unlock Moderna (MRNA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$27.53 (-12.35%)

$26.89 (-10.26%)

$26 (-7.19%)

$37.29 (-35.29%)

1year

6month

3month

1month

MRNA Analysts Opinion

MRNA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

MRNA Analysts Opinion

MRNA Analysts opinion is positive but there was a setback from the past 3 months

MRNA Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

55%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

25%

82%

MRNA Street Opinion

MRNA Street view is bullish and have positive views on the near-term outlook

MRNA Risk Level

MRNA has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low

LOW

HIGH

MRNA Performance Sentiment

Sentiments overview associated with MRNA events and the stock performance.

55%

39%

Positive

Negative

21 out of 38
events present

15 out of 38
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$27.16

Resistance
Price

$24.70

Current Price Range

$28.49

Show methods +

MRNA Earnings

The TTM data reflects the most recent 12-month period, providing overview of MRNA financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

3,055

3,199

6,754

-32.74%

Cost of Revenue

1,462

1,464

4,693

-44.19%

Gross Profit

1,593

1,735

2,061

-12.08%

Operating Exp

4,866

5,680

6,300

-12.11%

Operating Inc

-3,273

-3,945

-4,239

-

Net Interest Inc

351

401

383

-4.27%

Interest Exp

14

24

38

-39.30%

Interest Inc

365

425

421

-6.89%

Other Inc Exp

-23

-63

-86

-

EPS Growth

-7.51

-9.28

-12.33

-

MRNA Financial Health

The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals

Financial Score

2.34

Next Earnings Date: Nov 6, 2025

MRNA Latest Analysis

Moderna posts Q3 beat even as weak vaccine sales drive revenue slump.

Today

$24.13 | +2.33%

Activity

Momentum

Moderna Surges. Covid Vaccine Sales Decline But Top Expectations.

Today

$24.13 | +2.33%

Activity

Earnings

Moderna GAAP EPS of -$0.51 beats by $1.67 revenue of $1.02B beats by $150.11M.

Today

$24.13 | +2.33%

Earnings

Earnings Snapshot: Moderna tops Q3 guides FY revenue below consensus after 47% COVID-19 vaccine sales drop.

Today

$24.13 | +2.33%

Earnings

Moderna (MRNA) Stock Is Trading Lower Friday: Whats Going On?. MRNA) shares are trading lower on Friday afternoon giving back a portion of the gains seen on Thursday. Here’.s what investors need to know.The optimism from the rumor appears to have been tempered by the company’.s recent clinical and financial outlook. On Oct. 23 Moderna it was stopping its Phase 3 trial for its cytomegalovirus vaccine mRNA-1647 after it failed to ...

Fri Oct 31, 2025

$27.16 | -3.48%

Momentum

Moderna: Focus On Cancer Vaccines Not Buyout.

Fri Oct 31, 2025

$27.16 | -3.48%

Activity

Moderna gains on report it held talks with at least one large drugmaker.

Thu Oct 30, 2025

$28.14 | +13.93%

Momentum

Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline. Moderna (MRNA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thu Oct 30, 2025

$28.14 | +13.93%

Earnings

Notable Friday Option Activity: MRNA MDB RKLB. Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Moderna Inc (Symbol: MRNA) where a total of 91472 contracts have traded so far representing approximately 9.1 million underlying shares. That amounts to about 99.2% o

Fri Oct 24, 2025

$26.74 | +1.87%

Momentum

UBS Maintains Moderna (MRNA) Buy Recommendation. Fintel reports that on October 23 2025 UBS maintained coverage of Moderna (NasdaqGS:MRNA) with a Buy recommendation. Analyst Price Forecast Suggests 80.47% Upside

Fri Oct 24, 2025

$26.74 | +1.87%

Rating

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRNA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MRNA Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRNA Stock trends

MRNA Stock performance

MRNA Stock analysis

MRNA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRNA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRNA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

MRNA Stock Analysis & IQ Rating | Moderna

MRNA Stock IQ

MRNA Target Price

MRNA Risk Level

MRNA Analysts Opinion

MRNA Street Consensus

MRNA Performance Sentiment

Technical Price Levels

MRNA Financial Health

Explore our MRNA Stock insights

Receive our MRNA Daily Alerts

MRNA Stock IQ

MRNA Street Consensus

MRNA Risk Level

Technical Price Levels

Discover MRNA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRNA. We're here to help you make informed investment decisions today.

Receive our MRNA Daily Alerts

MRNA Runner Alarm